The Sanford guide to antimicrobial therapy 2014 / editors: David N. Gilbert [and others].

Colaborador(es): Gilbert, David N., M.D | Chambers, Henry F., M.D | Eliopoulos, George M., M.D | Saag, Michael S., M.D | Black, Douglas, Pharm.D | Freedman, David O., M.D | Pavia, Andrew T., M.D | Schwatz, Brian S., M.DTipo de material: TextoTextoEditor: Sperryville, Va. : Antimicrobial Therapy, 2014Edición: 44th edDescripción: 243 pages : il. (principalmente tablas) ; 21 cmISBN: 193080878X; 9781930808782; 1930808798; 9781930808799Otro título: Guide to antimicrobial therapyTema(s): ANTIBIÓTICOS -- USO TERAPÉUTICO -- MANUALES | AGENTES ANTIBACTERIALES -- MANUALES -- USO TERAPÉUTICOClasificación CDD: 616.014
Contenidos:
Abbreviations 2 (2) Table 1 Clinical Approach to Initial Choice of Antimicrobial Therapy 4 (64) Table 2 Recommended Antimicrobial Agents Against Selected Bacteria 68 (3) Table 3 Suggested Duration of Antibiotic Therapy in Immunocompetent Patients 71 (1) Table 4 Comparison of Antibacterial Spectra 72 (6) Table 5A Treatment Options For Systemic Infection Due To Multi-Drug Resistant Gram-Positive Bacteria 78 (1) Table 5B Treatment Options for Systemic infection Due to Selected Multi-Drug Resistant Gram-Negative Bacilli 78 (1) Table 6 Suggested Management of Suspected or Culture-Positive Community-Associated Methicillin-Resistant S. aureus Infections 79 (1) Table 7 Drug Desensitization methods 80 (1) Table 8 Risk Categories of Antimicrobics in Pregnancy 81 (1) Table 9A Selected Pharmacologic Features of Antimicrobial Agents 82 (9) Table 9B Pharmacodynamics of Antibacterials 91 (1) Table 9C Enzyme and Transporter-Mediated Interactions of Antimicrobials 91 (1) Table 10A Antibiotic Dosage and Side-Effects 92 (11) Table 10B Selected Antibacterial Agents---Adverse Reactions---Overview 103 (5) Table 10C Antimicrobial Agents Associated with Photosensitivity 108 (1) Table 10D Aminoglycoside Once-Daily and Multiple Dally Dosing Regimens 109 (1) Table 10E Prolonged or Continuous Infusion Dosing of Selected Beta Lactams 110 (1) Table 10F Inhalation Antibiotics 111 (1) Table 11A Treatment of Fungal Infections---Antimicrobial Agents of Choice 112 (13) Table 11B Antifungal Drugs: Dosage, Adverse Effects. Comments 125 (3) Table 11C At A Glance Summary of Suggested Antifungal Drugs Against Treatable Pathogenic Fungi 128 (1) Table 12A Treatment of Mycobacterial Infections 129 (11) Table 12B Dosage and Adverse Effects of Antimycobacterial Drugs 140 (3) Table 13A Treatment of Parasitic Infections 143 (11) Table 13B Dosage and Selected Adverse Effects of Antiparasitic Drugs 154 (3) Table 13C Parasites that Cause Eosinophilia (Eosinophilia In Travelers) 157 (1) Table 13D Sources for Hard-to-Find Antiparasitic Drugs 157 (1) Table 14A Antiviral Therapy 158 (13) Table 14B Antiviral Drugs (Non-HIV) 171 (4) Table 14C At A Glance Summary of Suggested Antiviral Agents Against Treatable Pathogenic Viruses 175 (1) Table 14D Antiretroviral Therapy (ART) In Treatment-Naive Adults (HIV/AIDS) 176 (13) Table 14E Antiretroviral Drugs and Adverse Effects 189 (4) Table 14F Hepatitis A & HBV Treatment 193 (1) Table 14G HCV Treatment Regimens and Response 193 (4) Table 15A Antimicrobial Prophylaxis for Selected Bacterial Infections 197 (1) Table 15B Antibiotic Prophylaxis to Prevent Surgical Infections in Adults 198 (4) Table 15C Antimicrobial Prophylaxis for the Prevention of Bacterial Endocarditis in Patients with Underlying Cardiac Conditions 202 (1) Table 15D Management of Exposure to HIV-1 and Hepatitis B and C 203 (4) Table 15E Prevention of Selected Opportunistic Infections in Human Hematopoietic Cell Transplantation (HCT) or Solid Organ Transplantation (SOT) in Adults With Normal Renal Function 207 (2) Table 16 Pediatric Dosages of Selected Antibacterial Agents 209 (1) Table 17A Dosages of Antimicrobial Drugs in Adult Patients with Renal Impairment 210 (9) Table 17B No Dosage Adjustment with Renal Insufficiency by Category 219 (1) Table 17C Antimicrobial Dosing in Obesity 219 (1) Table 18 Antimicrobials and Hepatic Disease: Dosage Adjustment 220 (1) Table 19 Treatment of CAPD Peritonitis in Adults 220 (1) Table 20A Anti-Tetanus Prophylaxis, Wound Classification, Immunization 221 (1) Table 20B Rabies Postexposure Prophylaxis 222 (1) Table 21 Selected Directory of Resources 223 (1) Table 22A Anti-Infective Drug-Drug Interactions 224 (7) Table 22B Drug-Drug Interactions Between Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) and Protease Inhibitors 231 (1) Table 23 List of Generic and Common Trade Names 232 (2) Index Of Major Entities 234
Resumen: El contenido está organizado en las tablas que cubren todos los aspectos de tratamiento más amplia información de medicamentos anti-infecciosos y muchas herramientas útiles. Las recomendaciones se basan en la evidencia y ampliamente referenciada. Generaciones de médicos han confiado en esta edición para ayudarles a tomar decisiones de tratamiento en el punto de atención. El contenido se ha actualizado para reflejar las recomendaciones actuales de mejor evidencia para el tratamiento de infecciones bacterianas, fúngicas, micobacterias, infecciones parasitarias y virales, medicamentos recientemente aprobados, nuevas indicaciones para medicamentos y referencias existentes a los nuevos informes en la literatura.
Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Ingresar para agregar etiquetas.
    Valoración media: 0.0 (0 votos)
Tipo de ítem Ubicación actual Colección Signatura Info Vol Copia número Estado Fecha de vencimiento Código de barras Reserva de ítems
LIBRO - MATERIAL GENERAL LIBRO - MATERIAL GENERAL Biblioteca Jorge Álvarez Lleras
Fondo general
Colección / Fondo / Acervo / Resguardo 616.014 S224 44a ed. (Navegar estantería) Ej. 1 1 Prestado 2020-12-18 023760
Total de reservas: 0

Incluye Indice

Préstamo permanente a Biblioteca Medica

Abbreviations 2 (2)
Table 1 Clinical Approach to Initial Choice of Antimicrobial Therapy
4 (64)
Table 2 Recommended Antimicrobial Agents Against Selected Bacteria
68 (3)
Table 3 Suggested Duration of Antibiotic Therapy in Immunocompetent Patients
71 (1)
Table 4 Comparison of Antibacterial Spectra
72 (6)
Table 5A Treatment Options For Systemic Infection Due To Multi-Drug Resistant Gram-Positive Bacteria
78 (1)
Table 5B Treatment Options for Systemic infection Due to Selected Multi-Drug Resistant Gram-Negative Bacilli
78 (1)
Table 6 Suggested Management of Suspected or Culture-Positive Community-Associated Methicillin-Resistant S. aureus Infections
79 (1)
Table 7 Drug Desensitization methods
80 (1)
Table 8 Risk Categories of Antimicrobics in Pregnancy
81 (1)
Table 9A Selected Pharmacologic Features of Antimicrobial Agents
82 (9)
Table 9B Pharmacodynamics of Antibacterials
91 (1)
Table 9C Enzyme and Transporter-Mediated Interactions of Antimicrobials
91 (1)
Table 10A Antibiotic Dosage and Side-Effects
92 (11)
Table 10B Selected Antibacterial Agents---Adverse Reactions---Overview
103 (5)
Table 10C Antimicrobial Agents Associated with Photosensitivity
108 (1)
Table 10D Aminoglycoside Once-Daily and Multiple Dally Dosing Regimens
109 (1)
Table 10E Prolonged or Continuous Infusion Dosing of Selected Beta Lactams
110 (1)
Table 10F Inhalation Antibiotics
111 (1)
Table 11A Treatment of Fungal Infections---Antimicrobial Agents of Choice
112 (13)
Table 11B Antifungal Drugs: Dosage, Adverse Effects. Comments
125 (3)
Table 11C At A Glance Summary of Suggested Antifungal Drugs Against Treatable Pathogenic Fungi
128 (1)
Table 12A Treatment of Mycobacterial Infections
129 (11)
Table 12B Dosage and Adverse Effects of Antimycobacterial Drugs
140 (3)
Table 13A Treatment of Parasitic Infections
143 (11)
Table 13B Dosage and Selected Adverse Effects of Antiparasitic Drugs
154 (3)
Table 13C Parasites that Cause Eosinophilia (Eosinophilia In Travelers)
157 (1)
Table 13D Sources for Hard-to-Find Antiparasitic Drugs
157 (1)
Table 14A Antiviral Therapy
158 (13)
Table 14B Antiviral Drugs (Non-HIV)
171 (4)
Table 14C At A Glance Summary of Suggested Antiviral Agents Against Treatable Pathogenic Viruses
175 (1)
Table 14D Antiretroviral Therapy (ART) In Treatment-Naive Adults (HIV/AIDS)
176 (13)
Table 14E Antiretroviral Drugs and Adverse Effects
189 (4)
Table 14F Hepatitis A & HBV Treatment
193 (1)
Table 14G HCV Treatment Regimens and Response
193 (4)
Table 15A Antimicrobial Prophylaxis for Selected Bacterial Infections
197 (1)
Table 15B Antibiotic Prophylaxis to Prevent Surgical Infections in Adults
198 (4)
Table 15C Antimicrobial Prophylaxis for the Prevention of Bacterial Endocarditis in Patients with Underlying Cardiac Conditions
202 (1)
Table 15D Management of Exposure to HIV-1 and Hepatitis B and C
203 (4)
Table 15E Prevention of Selected Opportunistic Infections in Human Hematopoietic Cell Transplantation (HCT) or Solid Organ Transplantation (SOT) in Adults With Normal Renal Function
207 (2)
Table 16 Pediatric Dosages of Selected Antibacterial Agents
209 (1)
Table 17A Dosages of Antimicrobial Drugs in Adult Patients with Renal Impairment
210 (9)
Table 17B No Dosage Adjustment with Renal Insufficiency by Category
219 (1)
Table 17C Antimicrobial Dosing in Obesity
219 (1)
Table 18 Antimicrobials and Hepatic Disease: Dosage Adjustment
220 (1)
Table 19 Treatment of CAPD Peritonitis in Adults
220 (1)
Table 20A Anti-Tetanus Prophylaxis, Wound Classification, Immunization
221 (1)
Table 20B Rabies Postexposure Prophylaxis
222 (1)
Table 21 Selected Directory of Resources
223 (1)
Table 22A Anti-Infective Drug-Drug Interactions
224 (7)
Table 22B Drug-Drug Interactions Between Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) and Protease Inhibitors
231 (1)
Table 23 List of Generic and Common Trade Names
232 (2)
Index Of Major Entities 234

El contenido está organizado en las tablas que cubren todos los aspectos de tratamiento más amplia información de medicamentos anti-infecciosos y muchas herramientas útiles. Las recomendaciones se basan en la evidencia y ampliamente referenciada. Generaciones de médicos han confiado en esta edición para ayudarles a tomar decisiones de tratamiento en el punto de atención. El contenido se ha actualizado para reflejar las recomendaciones actuales de mejor evidencia para el tratamiento de infecciones bacterianas, fúngicas, micobacterias, infecciones parasitarias y virales, medicamentos recientemente aprobados, nuevas indicaciones para medicamentos y referencias existentes a los nuevos informes en la literatura.

No hay comentarios en este titulo.

para colocar un comentario.

Haga clic en una imagen para verla en el visor de imágenes